By Neha Mathur Aug 17 2023 Reviewed by Sophia Coveney In a recent article published in Scientific Reports, researchers evaluated distinct immune responses to messenger ribonucleic acid (mRNA) and vector-based coronavirus disease 2019 (COVID-19) vaccines, and natural severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections. Study: Class switch towards spike protein-specific IgG4 antibodies after SARS-CoV-2 mRNA...
